Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

The clinical efficacy of pocket creation method ESD and conventional ESD in the treatment of early colorectal neoplasms: a meta-analysis

View through CrossRef
Background This study systematically evaluated the efficacy and safety of the pocket creation method endoscopic submucosal dissection (PCM-ESD) compared with conventional endoscopic submucosal dissection (C-ESD) in the treatment of early colorectal neoplasms. Methods A comprehensive search was conducted across PubMed, The Cochrane Library, Embase, CNKI, VIP, and Wan Fang databases for all case–control studies published from the inception of these databases to June 30, 2025, comparing PCM-ESD with C-ESD in the treatment of early colorectal neoplasms. Literature screening and data extraction were performed in accordance with predefined inclusion and exclusion criteria. Meta-analysis was performed using RevMan 5.4 software to assess the efficacy and safety of both methods. Results Nine studies, including 2 randomized controlled trials and 7 retrospective cohort studies with a total of 1,899 patients, were included. PCM-ESD achieved higher en bloc resection rates (RR = 1.05, 95%CI: 1.02 ~ 1.09, p  = 0.004) and complete (R0) resection rates (OR = 2.34, 95% CI: 1.62–3.39, p  < 00001) than C-ESD. Superior outcomes were also observed in fibrotic lesions (OR 1.67; 95% CI 1.14–2.43; p  = 0.008) and LST-NG-type polyps (OR 1.39; 95% CI 1.09–1.79; p  = 0.009). No significant differences were found in non-curative resection rates (OR 0.83; 95% CI 0.52–1.30; p  = 0.41). PCM-ESD demonstrated shorter procedure time (min) (MD − 10.61; 95% CI − 15.41 to −5.80; p  < 0.0001) and faster dissection speed (mm2/min) (MD 4.56; 95% CI 3.19–5.92; p  < 0.00001). Perforation rates were lower with PCM-ESD (OR 0.41; 95% CI 0.20–0.81; p  = 0.01), while bleeding rates were comparable (OR 1.03; 95% CI 0.51–2.05; p  = 0.94). Specimen size was larger in the PCM-ESD group (MD 2.83; 95% CI 0.66–5.00; p  = 0.01). Postoperative pathology revealed no difference in submucosal invasion depth (OR 0.94; 95% CI 0.69–1.28; p  = 0.69). Conclusion In the treatment of early colorectal neoplasms, PCM-ESD was associated with higher en bloc and R0 resection rates, shorter procedure time, faster dissection speed, and a lower perforation rate compared with C-ESD. In contrast, no statistically significant differences were observed between the two techniques with respect to non-curative resection rates, pathological outcomes, or bleeding-related events. While several efficacy and safety-related indicators favored PCM-ESD, these findings should be interpreted with caution given the predominance of retrospective data and the heterogeneity of study designs. Overall, PCM-ESD appears to be a promising alternative technique, particularly for technically challenging lesions. Systematic review registration https://www.crd.york.ac.uk/prospero/ , CRD420251147333.
Title: The clinical efficacy of pocket creation method ESD and conventional ESD in the treatment of early colorectal neoplasms: a meta-analysis
Description:
Background This study systematically evaluated the efficacy and safety of the pocket creation method endoscopic submucosal dissection (PCM-ESD) compared with conventional endoscopic submucosal dissection (C-ESD) in the treatment of early colorectal neoplasms.
Methods A comprehensive search was conducted across PubMed, The Cochrane Library, Embase, CNKI, VIP, and Wan Fang databases for all case–control studies published from the inception of these databases to June 30, 2025, comparing PCM-ESD with C-ESD in the treatment of early colorectal neoplasms.
Literature screening and data extraction were performed in accordance with predefined inclusion and exclusion criteria.
Meta-analysis was performed using RevMan 5.
4 software to assess the efficacy and safety of both methods.
Results Nine studies, including 2 randomized controlled trials and 7 retrospective cohort studies with a total of 1,899 patients, were included.
PCM-ESD achieved higher en bloc resection rates (RR = 1.
05, 95%CI: 1.
02 ~ 1.
09, p  = 0.
004) and complete (R0) resection rates (OR = 2.
34, 95% CI: 1.
62–3.
39, p  < 00001) than C-ESD.
Superior outcomes were also observed in fibrotic lesions (OR 1.
67; 95% CI 1.
14–2.
43; p  = 0.
008) and LST-NG-type polyps (OR 1.
39; 95% CI 1.
09–1.
79; p  = 0.
009).
No significant differences were found in non-curative resection rates (OR 0.
83; 95% CI 0.
52–1.
30; p  = 0.
41).
PCM-ESD demonstrated shorter procedure time (min) (MD − 10.
61; 95% CI − 15.
41 to −5.
80; p  < 0.
0001) and faster dissection speed (mm2/min) (MD 4.
56; 95% CI 3.
19–5.
92; p  < 0.
00001).
Perforation rates were lower with PCM-ESD (OR 0.
41; 95% CI 0.
20–0.
81; p  = 0.
01), while bleeding rates were comparable (OR 1.
03; 95% CI 0.
51–2.
05; p  = 0.
94).
Specimen size was larger in the PCM-ESD group (MD 2.
83; 95% CI 0.
66–5.
00; p  = 0.
01).
Postoperative pathology revealed no difference in submucosal invasion depth (OR 0.
94; 95% CI 0.
69–1.
28; p  = 0.
69).
Conclusion In the treatment of early colorectal neoplasms, PCM-ESD was associated with higher en bloc and R0 resection rates, shorter procedure time, faster dissection speed, and a lower perforation rate compared with C-ESD.
In contrast, no statistically significant differences were observed between the two techniques with respect to non-curative resection rates, pathological outcomes, or bleeding-related events.
While several efficacy and safety-related indicators favored PCM-ESD, these findings should be interpreted with caution given the predominance of retrospective data and the heterogeneity of study designs.
Overall, PCM-ESD appears to be a promising alternative technique, particularly for technically challenging lesions.
Systematic review registration https://www.
crd.
york.
ac.
uk/prospero/ , CRD420251147333.

Related Results

Efficacy and safety of pretraction-assisted endoscopic submucosal dissection for treating rectal neuroendocrine tumors
Efficacy and safety of pretraction-assisted endoscopic submucosal dissection for treating rectal neuroendocrine tumors
Abstract Background Multiple endoscopic treatment options are available for rectal neuroendocrine tumors (NETs), with conventional endoscopic submucosal dissection (c-ESD)...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
927 Traction-Assisted Endoscopic Submucosal Dissection Reduces Procedure Time and Risk of Adverse Events: A Meta-Analysis
927 Traction-Assisted Endoscopic Submucosal Dissection Reduces Procedure Time and Risk of Adverse Events: A Meta-Analysis
INTRODUCTION: Endoscopic submucosal dissection (ESD) is superior to endoscopic mucosal resection (EMR) for treatment of superficial gastrointestinal neoplasia because i...
Draft Recommendations on Classification of Rodent Neoplasms for Peto Analysis
Draft Recommendations on Classification of Rodent Neoplasms for Peto Analysis
The Executive Committee of the Society of Toxicologic Pathology appointed an ad hoc working group to review the current use of the Peto model for statistical analysis of rodent car...
Epidemiological profile of central nervous system neoplasms in the last decade
Epidemiological profile of central nervous system neoplasms in the last decade
Background: The epidemiological profile is one of the fundamental pillars of public health as it offers a detailed view of the health condition of a population. It is observed that...
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract Introduction: Current study found that about one-third of the incidence of colorectal cancer have genetic related. Hereditary nonpolyposis colorectal cancer...

Back to Top